Kristie L. Kahl

Researchers evaluates microsatellite instability-high status, tumor mutation burden and high PD-L1 expression to determine which grade of tumors would benefit from immunotherapy treatment among women with endometrioid endometrial cancer.

Albeit growing popularity of at-home genetic testing, it is still necessary to seek professional medical opinions from genetic counselors to help discuss results.

Berubicin showed promise in the treatment of glioblastoma as a drug that was able to cross the blood-brain barrier.

If patients with colon cancer follow the previously-issued American Cancer Society guidelines on nutrition and physical activity, they can improve outcomes in to survivorship.

As part of the Prostate Cancer Foundation’s first annual campaign, Kristen Bell selected two winners because of their ‘candor and honesty’ to be honored.

While previous studies showed bright white light therapy could prevent cancer-related fatigue, researchers also found it improves poor sleep efficiency among a variety of tumor types.

Israeli study shows cannabis is safe and effective for the palliative treatment of patients with cancer.

Despite exciting developments of PARP inhibitors over the years, limited knowledge exists in the mechanism of PARP-7 and its potential effect in targeted therapy for patients with ovarian cancer.

After his own journey with prostate cancer, radio and TV personality Ed Randall used his extensive connections throughout professional sports to spread awareness about prostate cancer through his nonprofit organization Fans for the Cure.

The Food and Drug Administration (FDA) granted priority review to dacomitinib for the first-line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR-activating mutations, according to Pfizer, the drug’s manufacturer.

Following fertility clinic malfunctions in Cleveland and San Francisco, many patients who have or had cancer are facing devastating losses, leaving many questions in the wake of these events.

As checkpoint inhibitors have changed the treatment landscape for many cancers, three specific biomarkers identified a subgroup of women with cervical and ovarian cancer tumor types who may benefit from such therapies.

Although genomic profiling successfully identifies those with microsatellite instability status who may benefit from PD-1 inhibitor therapy, a vast amount of women may be missed if they are not also tested for high tumor mutation burden too.

What do Bill Nye the Science Guy, fashion designer Michael Kors and one very special prostate cancer advocate all have in common? Blue jackets, a runway and the ultimate goal of raising awareness for prostate cancer.

The Right-to-Try bill recently passed in the United States House of Representatives.

After a recent FDA approval for an additional dosing schedule option for Opdivo, patients must be educated on the potential side effects that may occur between prolonged visits.

In this episode, we’ll talk with founder Donna Deegan herself about the foundation and its efforts, as well as the foundation’s executive director Amanda Napolitano on how much they have raised so far, and we’ll hear from one very inspiring participant Hollis Youngner.

Improved communication strategies are needed to address gaps between researchers and those in underserved populations, as well as their community providers.

With just one catwalk, the Prostate Cancer Foundation brought together celebrities, fashion designers and a special patient advocate to raise awareness for prostate cancer.

Next-generation sequencing could help identify MSI-H status in patients, which could have important implications for treatment plans.

Fear of recurrence is one of the most prominent concerns for patients with cancer, but oncology team interventions may play an important role in helping.

Cognitive dysfunction among geriatric patients with blood cancers – such as multiple myeloma, leukemia and lymphoma – is not only prevalent, but may also impact long-term survival.

Tony Beasley has spent years in the MLB as a third-base coach for the Texas Rangers. Little did he know his competitive nature and critical thinking would come in to play in his fight against stage 2 colorectal cancer. Since, Beasley has teamed up with Fight CRC as part of their One Million Strong Campaign to help others do one thing: Develop a mentality to fight.

TransCelerate BioPharma, a non-profit organization, launched a campaign to address the high demands and low enrollment of clinical trials for cancer treatment.

The agency determined the Personal Genome Service Genetic Health Risk (GHR) Report is accurate and can provide reproducible results.

The DONNA Foundation hosted its 11th annual marathon weekend in support of research and providing financial assistance to women with breast cancer.

Researchers from Texas A&M University found that circadian rhythms may be key in the timing of when chemotherapy is administered to patients with glioblastoma.

Hodgkin lymphoma survivors may be more likely to develop subsequent estrogen receptor (ER)-negative or -positive breast cancer compared to the general population.

To help educate patients and enable health care teams to effectively manage these side effects, the National Comprehensive Cancer Network (NCCN) and the American Society of Clinical Oncology (ASCO) issued new guidelines on understanding and managing immunotherapy-related toxicities.

An abnormal protein found in the blood – called monoclonal gammopathy of undetermined significance (MGUS) – may lead to multiple myeloma progression, even after 30 years of disease stability, according to study results published in the New England Journal of Medicine.